Search results
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 3 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 6 hours agoThey are also safe and effective at preventing the development of specific infections....
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 6 days agoSurgery or vaccines can trigger it. The Advisory Committee on Immunization Practices is closely...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 6 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 6 days agoThere are already two approved vaccines for those aged 60 and over, by GSK and Pfizer, both of which have been on the market since last year. "The...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via AOL· 6 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
Thousands of cancer patients to trial personalised vaccines
BBC via AOL· 7 days agoOne hope is that the vaccines will produce fewer side effects than conventional chemotherapy. Elliot...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 3 days agoThe vaccine, a critical component of Moderna’s pipeline, has bolstered investor confidence following...
Analysis | Four questions for today’s Fauci hearing
Washington Post· 3 days agoThe Texas Supreme Court rejected a lawsuit that sought to clarify exceptions to the state’s abortion laws. The longtime infectious-disease expert is back...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoResearchers from NYU Langone Health's Perlmutter Cancer Center are presenting their latest findings and research at the 2024 American Society of Clinical Oncology (ASCO) Annual Conference, held ...